Related Experiment Video
Updated: Aug 24, 2026
Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left
Lawrence Liao1, Christopher H Cabell, James G Jollis
1Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA. liao0002@mc.duke.edu
Insights
Identifying viable heart muscle with dobutamine stress echocardiography significantly improves survival in coronary disease patients. Revascularization in patients with viable myocardium offers a survival advantage over those without.
Area of Science:
- Cardiology
- Echocardiography
- Cardiac Imaging
Background:
- Severe left ventricular dysfunction poses a significant prognostic challenge.
- Identifying myocardial viability is crucial for guiding therapeutic strategies.
Purpose of the Study:
- To evaluate the prognostic significance of myocardial viability detected by dobutamine stress echocardiography.
- To assess the impact of revascularization on survival in patients with severe left ventricular dysfunction.
Main Methods:
- Prospective study of 107 patients with coronary disease and severe left ventricular dysfunction.
- Dobutamine stress echocardiography was used to identify myocardial viability.
- Survival rates were analyzed at a mean follow-up of 27 months.
Main Results:
- Patients with viable myocardium who underwent revascularization showed a significant survival advantage.
- 2-year survival was 83.5% in the revascularized viable myocardium group versus 57.2% in others (p=0.0037).
Conclusions:
- Dobutamine stress echocardiography effectively identifies patients who benefit from revascularization.
- Myocardial viability assessment is a critical determinant of long-term survival in severe left ventricular dysfunction.
Abstract:
In 107 patients with coronary disease and severe left ventricular dysfunction, we examined the prognostic power of viability identified by dobutamine stress echocardiography. At a mean follow-up of 27 months, patients with viable myocardium who underwent revascularization had a significant survival advantage over all other patients (2-year survival 83.5% vs 57.2%, p = 0.0037).
